Although diagnostic criteria are lacking, several syndromes may prompt testing for this condition.
Hashimoto encephalopathy (HE) is a diagnosis that is often considered in patients with a steroid-responsive encephalitis and elevated thyroid peroxidase antibodies (TPOAb) or thyroglobulin antibodies (Lancet Neurol 2016; 15:391). Mental status changes, cognitive decline, movement disorders, ataxia, psychosis, and seizures have all been described to occur in HE. However, TPOAb are present in some healthy individuals and are nonspecific. Investigators sought to better characterize their single-center, retrospective cohort.
Of 43 patients with suspected HE and negative neuronal/glial antibodies in serum and cerebrospinal fluid, along with 74 patients randomly selected with diagnosis of possible autoimmune encephalitis, 24 had high TPOAb (>200 I…
Reviewing Author
DisclosuresConsultant/Advisory BoardAlexion Pharmaceuticals; Amgen; Astoria; Biogen; Bristol Myers Squibb; Celltrion; Genentech; Hoffmann-La Roche; Genzyme; EMD Serono; Immpact-Bio; Immunic Therapeutics; Kyverna; Lundbeck; Novartis; Sandoz; TG Therapeutics
Grant/Research SupportNational Institutes of Health; National Multiple Sclerosis Society; U.S. Department of Defense
Leadership Positions in Professional SocietiesConsortium of Multiple Sclerosis Centers (Treasurer)
DisclosuresConsultant/Advisory BoardAlexion Pharmaceuticals; Amgen; Astoria; Biogen; Bristol Myers Squibb; Celltrion; Genentech; Hoffmann-La Roche; Genzyme; EMD Serono; Immpact-Bio; Immunic Therapeutics; Kyverna; Lundbeck; Novartis; Sandoz; TG Therapeutics
Grant/Research SupportNational Institutes of Health; National Multiple Sclerosis Society; U.S. Department of Defense
Leadership Positions in Professional SocietiesConsortium of Multiple Sclerosis Centers (Treasurer)